FDA DEVICE FACTS
Reliance Lumbar IBF System
Reliance Medical Systems, LLC
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Reliance Lumbar IBF System is indicated for intervertebral body fusion of the spine in skeletally mature patients. The device systems are designed for use with autogenous bone graft to facilitate fusion. One device may be used per intervertebral space. The implants are intended to be used with legally cleared supplemental spinal fixation cleared for the implanted level. Reliance Medical Systems, LLC Lumbar IBF System The Reliance Lumbar IBF System, when used as an Intervertebral Body Fusion device is also intended for use at either one level or two contiguous levels in the lumbar spine, from L2 to S1, for the treatment of degenerative disc disease (DDD) with up to Grade 1 Spondylolisthesis. DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. The lumbar device is to be used in patients who have had six months of non-operative treatment.
Technological Modifications:
The subject Reliance Lumbar IBF system offers additional implant and instrument components. These include additional implant sizes for use in the Lumbar IBF System, specifically the 10x22, 30x26, 34x27, 45x18, 50x18, 55x18, 55x22, and 60x26mm implant sizes. Additional instruments submitted here as accessories to the Reliance Lumbar IBF System are the Reliance Lumbar Graft Impactor and the Reliance Lumbar Graft Block and Double Graft Block. Finally, the 45x18, 50x18, 55x18, 60x18, 45x22, 50x22, 55x22, 60x22, 60x24, and 60x26mm implant sizes have been made stronger by increasing the teeth depth on the superior and inferior surfaces.
There have been no changes to intended use, indications for use, function, principle of operation, materials, levels of attachment, method of insertion, or labeling.
Performance Data and Substantial Equivalence:
Based on risk analysis for the new implant sizes and design verification testing conducted on the Reliance Lumbar IBF System instruments, it was determined that the inclusion of these implants and instruments into the Reliance Lumbar IBF System does not create a new worst-case test condition for mechanical testing, performance testing, sterilization, biocompatibility, cleaning or packaging. Therefore, in accordance with the design control process, additional performance data was not necessary for the changes subject of this Special 510(k).
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。